Results 1 to 3 of 3

A Fresh Look at Exclusive Forum Provisions

USA - May 28 2019 One common feature of large M&A transactions is the almost inevitable stockholder litigation challenging the transaction. Initially, this litigation…

Martin J. Crisp, Keith F. Higgins, Paul M. Kinsella, Peter L. Welsh

Use of 'ticking fee' in Novartis-AveXis transaction

USA - November 14 2018 On 6 April 2018 Novartis AG entered into a definitive agreement to acquire AveXis, Inc - a US-based, clinical stage gene therapy company - for…

Martin J. Crisp, Michael DiMaio, John E. Sorkin

The SEC’s (Re-)Proposed Resource Extraction Issuer Disclosure Rule - An Update, Deep Dive and Selected Takeaways and Action Items for Issuers

USA - February 1 2016 During December, the Securities and Exchange Commission (SEC) issued its long-awaited proposed rule (the Rule) on the disclosure of resource…

Michael R. Littenberg